Skip to main content
. 2019 Jul 22;20(14):3581. doi: 10.3390/ijms20143581

Table 1.

The effects of brain natriuretic peptide (BNP) infusion on renal function, the renin angiotensin II aldosterone system and hemodynamics in normal subjects and patients with heart failure and hypertension.

Study/Reference Dosage of BNP pmol/kg/min GFR RPF Urine Volume Urine Na Urine cGMP Urine Aldo Plasma cGMP PRA AngII Plasma Aldo MAP HR CO SVR PCWP
Normal Subjects
McGregor. J. Clin. Endocrinol. Metab. 1990 [36] 2 ↑↔ *
Yoshimura. Circulation. 1991 [37] 30
Holmes. J. Clin. Endocrinol. Metab. 1993 [9] 2 ↓↔ *
Cheung. Clin. Sci. 1994 [38] 0.4
Florkowski. Am. J. Physiol. 1994 [39] 2(+ANP(2)) **
La Villa. J. Clin. Endocrinol. Metab. 1994 [40] 4
La Villa. Hypertension. 1995 [41] 0.25 and 0.5
Lazzeri. Cardiology. 1995 [42] 4, 8, 10, 12
Hunt. J Clin. Endocrinol. Metab. 1996 [43] 2 ↓↔ *
Yasue. J Card. Fail. 1996 [44] 30
Jensen. Am. J. Phy.1998 [35] 1, 2 and 4
Jensen. Clin. Sci. 1999 [5] 2 ↓ ***
van der Zander. Am. J. Physiol. 2003 [45] 4 ↓↔ *
Summarized ↓↔
Patients with Heart Failure
Yoshimura. Circulation. 1991 [37] 30
Marcus. Circulation. 1996 [46] 1 to 30
Yasue. J. Card. Fail. 1996 [44] 30
Lainchbury. HTN 1997 [47] 3.3
Abraham. J. Cardiac. fail. 1998 [48] 7.5, 15
Jensen. Clin. Sci. 1999 [5] 2
Wang. Am. J. Trans. Res. 2016 [49] A bolus followed by 2 to 6 for 72 h
Summarized
Patients with Hypertension
Richards. J. Hypertension. 1993 [50] 2 #
Lazzeri. Am. J. Hypertension. 1995 [51] 4
Pidgeon. Hypertension. 1996 [52] 2
Summarized

ANP, atrial natriuretic peptide; cGMP, cyclic guanosine monophosphate; CO, cardiac output; GFR, glomerular filtration rate; HR, heart rate; MAP, mean arterial pressure; PCWP, pulmonary capillary wedge pressure; PRA, plasma renin activity; RPF, renal plasma flow; SVR, systemic vascular resistance. * marginal significance. ** BNP(2)+ANP(2) vs ANP(2) alone. *** after the infusion. # Plasma renin concentration.